Healthcare -
Biotechnology - NASDAQ - US
$ 26.5
0.607 %
$ 2.22 B
Market Cap
-5.79
P/E
BEAM - STOCK-BASED COMPENSATION
Stock-based Compensation BEAM - Beam Therapeutics Inc.
98.6 M
LAST VALUE
50.47%
2 YEAR CAGR
69.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR